Independent batch analysis
Batch Verification
Passed all tests
99.51%
HPLC-UV result
9.91 mg
Reported result for tested sample
Confirmed
Compound identity result
No growth
Microbial-count results
0.16 EU/mL
LAL test result
<0.1 ppm
Reported metals result
Results are specific to batch CAG-260702-H6 and should not be generalized to any other lot. Review the complete certificate for full methods and results.
Product overview
Cagrilintide 10 mg Research Material
Cagrilintide is described in peer-reviewed scientific literature as a long-acting amylin analogue under clinical investigation. Research has examined cagrilintide alone and alongside other investigational compounds in controlled studies.
This Peptora product is supplied as lyophilized peptide material with a labelled quantity of 10 mg per vial. Elementrix reports a tested-sample quantity of 9.91 mg and a purity result of 99.51%.
Published studies listed below are provided strictly as scientific background. They do not establish that Peptora’s material is suitable for clinical use, and they are not instructions or recommendations for human or veterinary use.
Research Context at a Glance
Published scientific literature describes cagrilintide through amylin-analogue research:
Analogue research
Investigational design
This summary describes the investigational mechanism reported in scientific literature. It is not a statement of intended use for this laboratory material.
Batch documentation
Traceable From Product to Certificate
The product, batch identifier and Elementrix report are presented together so researchers can review the applicable certificate before ordering.
- ✓ Batch-specific COA available online
- ✓ Direct Elementrix verification link
- ✓ Reported purity, identity and net content
Expanded third-party review
More Than a Purity Percentage
This certificate reports identity, quantity, TAMC, TYMC, endotoxin and metals alongside purity—providing a broader documented testing profile.
The Peptora testing difference
We Test Beyond Purity
A purity percentage is only one part of a meaningful batch review. For batch CAG-260702-H6, Elementrix also reports identity, quantity, TAMC, TYMC, endotoxin and metals.
✓ Quantity
✓ LC-MS identity
✓ TAMC / TYMC
✓ Endotoxin
✓ Metals
One batch-specific Elementrix certificate with direct verification.
What the expanded panel covers
Purity and content
HPLC purity of 99.51% and a tested-sample quantity of 9.91 mg are reported against the certificate specifications.
Identity confirmation
LC-MS analysis is reported as confirming the identity of the material evaluated by Elementrix.
Microbial counts and endotoxin
The certificate reports no growth for both TAMC and TYMC, plus an endotoxin result below 0.0451 EU/mg.
Metals screening
The certificate reports a metals result below 100 ppb against a specification of less than 100 ppb.
Identity confirmation
The reported identity result is Cagrilintide and is marked compliant on Elementrix COA ELX-20260702-43745.
Direct verification
Report COA ELX-20260702-43745 can be checked through Elementrix so the certificate is not dependent on Peptora’s description alone.
Product care and fulfilment
Storage and Shipping
Storage
The Elementrix certificate for this batch does not state a storage temperature. Follow the product packaging and your laboratory’s validated storage and handling protocol.
Do not use the vial if its packaging or integrity appears compromised.
Ships from Ontario
Orders are fulfilled from Ontario, Canada. Review Peptora’s shipping information for current processing, delivery and order-handling details.
Documentation built in
Why Choose Peptora?
Peptora Peptide Labs is structured around transparent, batch-specific documentation for Canadian laboratory researchers.
Independent analysis
Testing results are documented through a third-party Elementrix certificate rather than an internal specification sheet alone.
Batch-specific COAs
The displayed certificate is tied to a defined report number and batch identifier for straightforward traceability.
Direct verification
Researchers can open the complete PDF and follow the independent verification link from the product page.
Canadian fulfilment
This research material ships from Ontario, Canada.
Clear intended use
Product presentation and documentation clearly identify the material as intended only for laboratory research.
Accessible documentation
Testing standards, certificates and product information are organized for review before ordering.
Product questions
Frequently Asked Questions
Clear answers about Cagrilintide 10 mg, its batch documentation, independent testing and intended use.
Important product restriction
For Laboratory Research Use Only
All Peptora Peptide Labs products are intended solely for controlled laboratory research. This material is not for human or veterinary consumption and is not intended for compounding, clinical use, diagnosis, treatment, cure or prevention of disease.
Peptora does not provide medical advice, dosing instructions, administration guidance or treatment recommendations.
Scientific background references
- Kruse T, et al. Development of Cagrilintide, a Long-Acting Amylin Analogue. Journal of Medicinal Chemistry. 2021.
- Lau DCW, et al. Once-weekly cagrilintide for weight management: a multicentre, randomised, double-blind, placebo-controlled and active-controlled, dose-finding phase 2 trial. The Lancet. 2021.
- Enebo LB, et al. Safety, tolerability, pharmacokinetics, and pharmacodynamics of concomitant administration of multiple doses of cagrilintide with semaglutide 2.4 mg. The Lancet. 2021.
References are provided for scientific background only. Published research does not validate this specific Peptora batch or authorize use of this product in humans or animals.
